Background: There is limited literature regarding adherence rates for the treatment of tuberculosis (TB) in children. We aimed to describe TB treatment outcomes and adherence as well as to evaluate associated factors to poor adherence in Mozambican children. Methods: This is a sub-study of a community TB incidence study among children <3 years of age. Incomplete adherence included the sum of lost-to-follow-up cases plus those with a delay of > 3 weeks to treatment completion. Results: Fifty TB treatments were assessed. Forty-four (88.0%) patients completed treatment, two (4.0%) died during treatment and four (8.0%) were lost to follow-up. Incomplete adherence was observed in 31.3% (15 of 48) of cases and was associated with malnutrition or history of a migrant mother. Conclusion: Although treatment outcome is overall good, there is still a significant proportion of incomplete adherence. Further larger paediatric TB cohorts and qualitative approaches are needed to assess and confirm potential factors for non-adherence.
treatment in children is complex and is influenced by patient and healthcare system factors, among others [9] . It depends on the understanding and motivation of caretakers, who frequently have limited awareness of the disease [3, 10] .
Studies on therapy for latent TB infection in children have shown low completion rates ranging from 44 to 78% [11] . Treatment outcomes for paediatric TB disease in the African region have also shown high rates of poor outcomes (deaths, treatment failures and lost to follow-up [LTFU]) ranging from 10 to 19% [12] [13] [14] [15] [16] [17] . However, there are few studies that report adherence and treatment duration [11] . In addition, there is limited data on associated barriers to anti-TB treatment in young children [11, [18] [19] [20] . Therefore, the aim of this study was to describe the treatment outcomes and adherence to TB treatment and to evaluate factors associated with poor adherence in Mozambican children aged <3 years.
M E T H O D O L O G Y

Settings
This study was conducted at the Manhiça District, Southern Mozambique, where the Manhiça Health Research Center runs a health and demographic surveillance system (HDSS) [21] . This setting has a high incidence of both TB and human immunodeficiency virus (HIV), with an estimated communitybased incidence rate of TB among children < 3 years of 470/100 000 person-years [22] [23] [24] and an estimated case detection rate of 41% [25] . TB treatment is offered at no cost to patients at the health units, and paediatric fixed-dose combinations are available following WHO 2010 dose recommendations [26] . At the time of the study implementation, paediatric TB treatment for smear-negative pulmonary cases and non-severe forms of extrapulmonary TB, included an intensive phase of 2 months of daily Isoniazid, Rifampicin and Pyrazinamide, followed by 4 months of daily Isoniazid and Rifampicin, with weekly and monthly clinical checks and drug collection, respectively [27] . All TB cases co-infected with HIV are managed in an integrated manner with the provision of cotrimoxazole preventive therapy and anti-retroviral therapy at TB clinics.
Study design
This is a sub-study of a larger prospective cohort study that assessed the minimum community incidence of TB among young children (<3 years of age) over a 1 year period (October 2011-12), whose detailed methodology and findings have previously been published [22] . Briefly, all presumptive TB cases were evaluated through physical and radiological examination, HIV and tuberculin skin testing, as well as smear microscopy and culture of both induced sputum and gastric aspirate samples. All participants had at least one follow-up visit arranged within 6 months of recruitment. All TB cases were registered with the National Tuberculosis Program (NTP) and managed according to established national clinical guidelines. Treatment was always initiated at the Manhiça District Hospital (MDH) and patients' care was then transferred to their corresponding peripheral health unit, if applicable. For the purpose of this analysis, TB cases were defined as any case registered to initiate TB treatment at the NTP during the study period. In the incidence study, TB cases followed the National Institute of Health case definition for childhood TB [28] (See Box 1).
Data collection and analysis
Demographic and clinical data were obtained at the initial visit, and follow-up clinical data were recorded at every subsequent visit. Other socio-demographic data were obtained through the HDSS 2012 data. Information on the WHO treatment category, followup visits, treatment outcome and adherence were retrospectively extracted from registers of the NTP into a structured data collection tool. Delays in treatment completion were calculated based on the registered date of treatment initiation and treatment completion.
Proportions were compared using the Fishe rs exact chi-squared test. Prevalence ratio (PR) and its 95% confidence intervals (CI) were calculated from poison regression with robust standard errors to measure the strength of the association between clinical and demographic factors and adherence categories. Programmatic data from the NTP at the MDH for other age groups during the same period were used for comparison. Statistical software for analysis was Stata 11.2 (StataCorp. 2013. Stata: Release 11, StataCorp LP, Statistical Software, College Station, TX). R E S U L T S Fifty children <3 years old consented to participate and initiated TB treatment in the district of Manhiça ( Tables 1 and 2 ). All were treated for drugsusceptible TB; nine cases were microbiologically confirmed on the basis of culture, although none of them was smear positive on microscopy for acid-fast bacilli. Of all children starting treatment, 26 (52.0%) were male and 24 (48.0%) were HIV infected. Although patients were followed up in 10 different peripheral healthcare centres, >64.0% of cases were managed by two single health centres, one of which was the MDH (30.0%).
Ethical considerations
All 50 cases had documented treatment outcomes: 44 (88.0%) children successfully completed treatment, Box 1. Relevant study definitions TB case: Any child registered to initiate TB treatment at the NTP during the study period. Study TB case: Includes microbiologically confirmed plus probable cases (adapted from the standardized NIH case definition for childhood TB [28] , full details on the classification are described elsewhere [22] 1. Cured: A pulmonary TB patient with bacteriologically confirmed TB at the beginning of treatment who was smear or culture negative in the last month of treatment and on at least one previous occasion) AND 2. Treatment completed: A TB patient who completed treatment without evidence of failure BUT with no record to show that sputum smear or culture results in the last month of treatment and on at least one previous occasion were negative, either because tests were not done or because results are unavailable. Treatment failed: A TB patient whose sputum smear or culture is positive at month 5 or later during treatment. Died: A TB patient who dies for any reason before starting or during the course of treatment. Lost to follow-up: A TB patient whose treatment was interrupted for two consecutive months or more. Not evaluated: A TB patient for whom no treatment outcome is assigned. This includes cases 'transferred out' to another treatment unit as well as cases for whom the treatment outcome is unknown to the reporting unit. Adherence categories were defined as: Incomplete adherence. The sum of the following two exclusive categories and calculated over those patients who did not die: 1. Lost to follow-up (patients whose treatment was interrupted for 2 consecutive months or more) AND 2. Delayed completion (patients with a delay of 3 weeks beyond the expected date (calculated as 6 months after treatment initiation)). Full adherence. All treatment success cases with no delay in treatment completion.
2 (4.0%) died before treatment completion and 4 (8.0%) were LTFU. There were no treatment failures nor transferred cases. Among treatment success cases, 11 (25.0%) had a delay in treatment completion, eight of which were males, over half HIV infected and one microbiologically confirmed TB case. Among the LTFU, three were males, all lived >2 km distance from the MDH, none fulfilled the study TB case definition and all were HIV-infected. Overall incomplete adherence (delayed plus LTFU) was reported in 31.3% (15 among the 48 patients who did not die) ( Table 3 ). Figure 1 shows the distribution of the number of days from treatment initiation to treatment completion. Eleven cases finished treatment before the expected date, eight of them 1-2 days earlier. One patient had a 74 day delay in treatment completion. Compared with other age groups registered at the MDH NTP during the same period, we found a higher treatment success rate in children <3 years (88% vs. 68.1% and 72.5% among patients aged 3-15 years and >15 years, respectively). However, incomplete adherence was similar in all groups. Figure 2 shows adherence results for these three age categories (final numbers exclude deaths).
Being malnourished at enrolment and having a mother with a history of migration in the previous 2 years to TB diagnosis were shown to be potential risk factors for incomplete adherence (PR: 2.9; 95% CI: 1.4-6.1 and PR: 2.9; 95% CI: 1.4-6.0, respectively, p < 0.05) ( Table 3) .
D I S C U S S I O N
Data on adherence to TB treatment in children are scarce. To our knowledge, this is the first study describing the profile and treatment outcomes among paediatric TB cases in Mozambique and one of the few reporting adherence and treatment outcomes in a well-characterized cohort of young children. Although the overall treatment success rate (88%) was close to the 90% Stop TB target [6] , there were still a significant proportion of paediatric TB cases with incomplete adherence (31.3%). Being malnourished and having a migrant mother were potential risk factors for incomplete adherence.
We have previously reported a treatment success rate of 67.3% among children aged <3 years in Manhiça during 2006-10 [25] . The significant improvement observed in the current study compared with the previous years can be owing to several reasons. First, to the substantial recent decrease in mortality, as improved TB/HIV care and treatment services are available at the health facilities. The proportion of patients who die during TB treatment has decreased from 17% during 2006-10 to 4% in this study 31] . Secondly, improved outcomes may be owing to a slight decrease in the number of LTFU (from 9.6% in 2006-10 to 8%) that could be influenced by the fact of being included in the epidemiological incidence study. Although the study had active follow-up visits, which could have positively influenced treatment adherence, the univariate analysis did not show an association.
The treatment success rate reported in this study is similar to the 87% estimated by WHO for all new cases in 2012 for Mozambique [5] . It decreased, however, in other age groups during the same period, reaching 68.1% and 72.5% in patients aged 3-15 years and >15 years, respectively. While other authors have also found higher success rates with younger ages [11] , Hailu et al. [18] found that being >5 years of age was a predictor of treatment success. Comparing TB treatment adherence results among different studies is difficult owing to the large variations in the definitions of adherence found in the literature, particularly for childhood TB [11, 17, 19, [32] [33] [34] [35] . As stated by Chang et al. [36] , it seems reasonable to consider LTFU and incomplete adherence as part of the same problem, with different levels of severity. Thus, for the purpose of this study, we used a definition of incomplete adherence that includes LTFU plus delayed completion. Despite the differences in the definitions, the results in this study are similar to other paediatric reports from high burden countries [17, 34, 35, 37] . Unpublished results from a recent meta-analysis show a treatment success rate of 81% with 3% mortality, with large variations among the studies included [12] .
We have identified several factors associated with incomplete adherence, many of them were expected and have been previously cited by other authors as predictors of poor outcome [13, 38, 39] . Evidence of chronic or acute malnutrition at diagnosis was associated with incomplete adherence. Several studies have also reported poor TB outcomes among malnourished children [38, 39] but in this study malnutrition was associated both with LTFU and death as well as with a delay in treatment completion. This suggests that beyond the deleterious immunological impact of malnutrition on TB progression, other aspects such as tolerance to drugs or, more importantly, the social context have an impact on adherence and outcome. The importance of the caregiver-child relationship has been shown to impact overall child survival, and thus, the history of migration of the mother seems to impact treatment adherence and outcomes [40] . Malnutrition was significantly associated with a history of a migrant mother, hospitalization at the time of diagnosis and TB case definition, and thus the specific impact of these other variables on adherence is difficult to interpret.
HIV co-infection is also a well-known risk factor for incomplete adherence in adults [2, [41] [42] [43] [44] , and children [19, 38] , partly owing to the increased pill burden and secondary effects. Because of the high treatment compliance rate (90%) required to facilitate cure and reduce the risk of rapid disease progression in children, the poor adherence observed among HIV-TB co-infected cases is cause for concern, as it could lead to increased mortality. Given the inherent difficulties in diagnosing paediatric TB, caregivers may sometimes reflect their uncertainty in the diagnosis by not fulfilling the treatment recommendations. This may be the underlying cause of the poorer adherence observed among cases not fulfilling the study TB definition. Moreover, TB diagnostic algorithms do not perform well among HIV coinfected children [28] . Given the HIV co-infection rate observed among confirmed and non-confirmed TB cases (10% and 51%, respectively), this may have played a role in hesitance of diagnosis and adherence to treatment. The gender difference observed in the current study was not statistically significant and needs to be further evaluated with larger sample sizes. Some adult studies have also noted a higher rate of incomplete adherence among males although this association needs to be further evaluated and may not be necessarily extrapolated to the paediatric population [44] [45] [46] [47] .
There are several limitations to this study. First, the small sample size of the cohort limits the ability to reach statistical significance for several potential associations (no multivariable logistic regression analysis was possible). Secondly, the analysis of adherence was performed using data measured indirectly with a retrospective design. In addition, the fact that most children starting treatment were part of a research study could have had a potential positive influence on adherence, although the study was focusing on case detection. Moreover, we did not register other common factors reported to influence adherence such as major side effects, who the main caregiver for the child was or the exact phase of the treatment where the main delay occurred. Furthermore, the results may be biased given that TB under-reporting is more common in severe forms of the disease in which the patients die before treatment initiation. Finally, we did not capture common system failures such as drug stock rupture or health personnel absenteeism, which might lead to non-patient-originated poor adherence.
In conclusion, although paediatric treatment outcome is overall good, there is still a significant proportion of incomplete adherence cases. This study setting may have represented an improved health system scenario, so the true program performance may show worse indicators. Reinforcing the importance of timely treatment completion should remain a high priority. Successful treatment of paediatric TB requires the commitment and involvement of the corresponding caregiver. Further larger paediatric TB cohorts and qualitative research are needed to assess and eventually address potential risk factors for non-adherence.
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